← FDA Drug Approvals (Drugs@FDA)
DAPTOMYCIN
NDA · New Drug Application · Sponsor: HOSPIRA · Approved 2021-06-21
Drug application
- FDA Application #
NDA210282- Application type
- New Drug Application
- Brand name
- DAPTOMYCIN
- Generic name
- DAPTOMYCIN
- Active ingredients
- DAPTOMYCIN
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- HOSPIRA
- Manufacturer
- Hospira, Inc.
- First approval
- 2021-06-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown